Challenges and progress in the development of a serogroup B meningococcal vaccine

被引：3
|
作者：
Lewis, Susan [1 ]
Sadarangani, Manish [1 ]
Hoe, J. Claire [1 ]
Pollard, Andrew J. [1 ]
机构：
[1] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Dept Paediat,Oxford Vaccine Grp, Oxford OX3 7LJ, England
来源：
EXPERT REVIEW OF VACCINES | 2009年 / 8卷 / 06期
关键词：
5CVMB; meningococcal disease; outer membrane protein; outer membrane vesicle vaccine; serogroup B; MEMBRANE-VESICLE VACCINE; INNER-CORE LIPOPOLYSACCHARIDE; MENINGITIDIS GROUP-B; H-BINDING PROTEIN; SYNERGISTIC BACTERICIDAL ACTIVITY; NEISSERIA-LACTAMICA PROTECTS; HUMAN-ANTIBODY RESPONSES; HUMAN SERUM ANTIBODIES; NEW-ZEALAND; ESCHERICHIA-COLI;
D O I：
10.1586/ERV.09.30
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Serogroup B meningococci cause the majority of the meningococcal disease burden in developed countries. Production of an effective and safe vaccine for serogroup B organisms has been hampered by the poor immunogenicity of the capsular polysaccharide that defines this group of bacteria. Previous efforts have focused on outer membrane vesicle vaccines, which have been implemented successfully during clonal outbreaks. However, the search for a universal vaccine against endemic polyclonal serogroup B meningococcal disease continues. In this review, we have highlighted recent development of outer membrane vesicle vaccines and progress in the evaluation of recombinant outer membrane protein vaccines.
引用
收藏
页码：729 / 745
页数：17
相关论文
共 50 条
  • [41] Challenges and progress in vaccine development
    不详
    VETERINARY RECORD, 2009, 165 (14) : 390 - 391
  • [42] Efficacy of serogroup C meningococcal polysaccharide vaccine
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (03) : 590 - 595
  • [43] Prevention of serogroup B meningococcal disease using a four-component vaccine
    Gil, A.
    Barranco, D.
    Batalla, J.
    Bayas, J. M.
    Campins, M.
    Gorrotxategi Gorrotxategi, P.
    Lluch, J.
    Martinon-Torres, F.
    Mellado, M. J.
    Moreno-Perez, D.
    Uriel, B.
    Vazquez, J. A.
    ANALES DE PEDIATRIA, 2014, 80 (04): : 259 - 260
  • [44] Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
    Bai, Xilian
    Findlow, Jamie
    Borrow, Ray
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (07) : 969 - 985
  • [45] First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
    McNamara, Lucy A.
    Shumate, Alice M.
    Johnsen, Peter
    MacNeil, Jessica R.
    Patel, Manisha
    Bhavsar, Tina
    Cohn, Amanda C.
    Dinitz-Sklar, Jill
    Duffy, Jonathan
    Finnie, Janet
    Garon, Denise
    Hary, Robert
    Hu, Fang
    Kamiya, Hajime
    Kim, Hye-Joo
    Kolligian, John, Jr.
    Neglia, Janet
    Oakley, Judith
    Wagner, Jacqueline
    Wagner, Kathy
    Wang, Xin
    Yu, Yon
    Montana, Barbara
    Tan, Christina
    Izzo, Robin
    Clark, Thomas A.
    PEDIATRICS, 2015, 135 (05) : 798 - 804
  • [46] Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease
    Watson, Philip S.
    Novy, Patricia L.
    Friedland, Leonard R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : 22 - 27
  • [47] Process development and immunogenicity studies on a serogroup 'X' Meningococcal polysaccharide conjugate vaccine
    Chilukuri, Srinivas Reddy
    Reddy, Peddi
    Avalaskar, Nikhil
    Mallya, Asha
    Pisal, Sambhaji
    Dhere, Rajeev M.
    BIOLOGICALS, 2014, 42 (03) : 160 - 168
  • [48] Neisseria meningitidis serogroup B vaccine development
    Caesar, Nicole M.
    Myers, Kenneth A.
    Fan, Xin
    MICROBIAL PATHOGENESIS, 2013, 57 : 33 - 40
  • [49] Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
    Micoli, Francesca
    Romano, Maria Rosaria
    Tontini, Marta
    Cappelletti, Emilia
    Gavini, Massimiliano
    Proietti, Daniela
    Rondini, Simona
    Swennen, Erwin
    Santini, Laura
    Filippini, Sara
    Balocchi, Cristiana
    Adamo, Roberto
    Pluschke, Gerd
    Norheim, Gunnstein
    Pollard, Andrew
    Saul, Allan
    Rappuoli, Rino
    MacLennan, Calman A.
    Berti, Francesco
    Costantino, Paolo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (47) : 19077 - 19082
  • [50] Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
    Martinelli, Domenico
    Fortunato, Francesca
    Cappelli, Maria Giovanna
    Cozza, Vanessa
    Chironna, Maria
    Prato, Rosa
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
12345